EUPRAXIA PHARMACEUTICALS INC. (EPRX) Insider Trading Disclosures
EUPRAXIA PHARMACEUTICALS INC. (EPRX) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: EPRX
CIK: 1581178
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: A1
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
KPMG LLP
Auditor SinceSince 12/31/2022 12:00:00 AM
Lead Engagement PartnerJason Bower
Audit LocationVancouver, Canada
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 6-K | 2026-10-15 | 2026-10-15 | FORM 6-K | 0001171843-26-006648 | View SEC Doc Filr Page |
| 6-K | 2026-10-09 | 2026-10-09 | FORM 6-K | 0001171843-26-006551 | View SEC Doc Filr Page |
| 6-K | 2026-09-30 | 2026-09-30 | FORM 6-K | 0001171843-26-006307 | View SEC Doc Filr Page |
| 6-K | 2026-09-08 | 2026-09-08 | FORM 6-K | 0001171843-26-005913 | View SEC Doc Filr Page |
| SUPPL | 2026-09-02 | — | SUPPL | 0001193125-26-379038 | View SEC Doc Filr Page |
| EFFECT | 2026-08-24 | — | EFFECT Filing | 9999999995-26-002742 | View SEC Doc Filr Page |
| F-10/A | 2026-08-19 | — | F-10/A | 0001193125-26-356803 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-13 | — | SCHEDULE 13G/A Filing | 0000919574-26-005070 | View SEC Doc Filr Page |
| 6-K | 2026-08-13 | 2026-08-13 | FORM 6-K | 0001171843-26-005479 | View SEC Doc Filr Page |
| 6-K | 2026-08-11 | 2026-08-11 | 6-K | 0001193125-26-345045 | View SEC Doc Filr Page |
| F-X | 2026-08-06 | — | F-X | 0001193125-26-336190 | View SEC Doc Filr Page |
| F-10 | 2026-08-06 | — | F-10 | 0001193125-26-336139 | View SEC Doc Filr Page |
| 6-K | 2026-07-15 | 2026-07-15 | FORM 6-K | 0001171843-26-004676 | View SEC Doc Filr Page |
| 6-K | 2026-07-13 | 2026-07-13 | FORM 6-K | 0001171843-26-004605 | View SEC Doc Filr Page |
| 6-K | 2026-07-07 | 2026-07-07 | FORM 6-K | 0001171843-26-004516 | View SEC Doc Filr Page |
| 6-K | 2026-06-22 | 2026-06-19 | FORM 6-K | 0001171843-26-004213 | View SEC Doc Filr Page |
| 6-K | 2026-05-29 | 2026-06-18 | FORM 6-K | 0001171843-26-003787 | View SEC Doc Filr Page |
| 6-K | 2026-05-29 | 2026-05-28 | FORM 6-K | 0001171843-26-003785 | View SEC Doc Filr Page |
| 6-K | 2026-05-28 | 2026-05-28 | FORM 6-K | 0001171843-26-003762 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-12 | — | SCHEDULE 13G/A Filing | 0000919574-26-002903 | View SEC Doc Filr Page |
| 6-K | 2026-05-12 | 2026-05-12 | 6-K | 0001193125-26-219802 | View SEC Doc Filr Page |
| 6-K | 2026-05-06 | 2026-05-06 | FORM 6-K | 0001171843-26-003051 | View SEC Doc Filr Page |
| 6-K | 2026-05-05 | 2026-05-05 | FORM 6-K | 0001171843-26-003003 | View SEC Doc Filr Page |
| 6-K | 2026-05-01 | 2026-05-01 | FORM 6-K | 0001171843-26-002939 | View SEC Doc Filr Page |
| 6-K | 2026-04-22 | 2026-04-22 | FORM 6-K | 0001171843-26-002633 | View SEC Doc Filr Page |